Trial · NCT02409290
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| STREAM Stage 2 Primary Outcome Measure (the Proportion of Patients With a Favourable Outcome at Week 76) | Regimen A (Long Regimen) | 0 | Participants | ||
| STREAM Stage 2 Primary Outcome Measure (the Proportion of Patients With a Favourable Outcome at Week 76) | Regimen B (Control Regimen) | 133 | Participants | ||
| STREAM Stage 2 Primary Outcome Measure (the Proportion of Patients With a Favourable Outcome at Week 76) | Regimen C (Oral Regimen) | 162 | Participants | ||
| STREAM Stage 2 Primary Outcome Measure (the Proportion of Patients With a Favourable Outcome at Week 76) | Regimen D (6-month Regimen) | 122 | Participants | ||
| Favourable Outcome After Long-term Follow-up (132 Weeks) | Regimen A (Long Regimen) | 17 | Participants | ||
| Favourable Outcome After Long-term Follow-up (132 Weeks) | Regimen B (Control Regimen) | 126 | Participants | ||
| Favourable Outcome After Long-term Follow-up (132 Weeks) | Regimen C (Oral Regimen) | 152 | Participants | ||
| Favourable Outcome After Long-term Follow-up (132 Weeks) | Regimen D (6-month Regimen) | 115 | Participants | ||
| Proportion of Patients With Acquired Drug Resistance | Regimen A (Long Regimen) | 0 | Participants | ||
| Proportion of Patients With Acquired Drug Resistance | Regimen B (Control Regimen) | 5 | Participants | ||
| Proportion of Patients With Acquired Drug Resistance | Regimen C (Oral Regimen) | 5 | Participants | ||
| Proportion of Patients With Acquired Drug Resistance | Regimen D (6-month Regimen) | 3 | Participants | ||
| Failure or Recurrence (FoR) | Regimen A (Long Regimen) | 0 | Participants | ||
| Failure or Recurrence (FoR) | Regimen B (Control Regimen) | 17 | Participants | ||
| Failure or Recurrence (FoR) | Regimen C (Oral Regimen) | 4 | Participants | ||
| Failure or Recurrence (FoR) | Regimen D (6-month Regimen) | 0 | Participants | ||
| Failure or Recurrence (FoR) | Regimen B (Control Regimen) | 14 | Participants | ||
| Failure or Recurrence (FoR) | Regimen D (6-month Regimen) | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02409290/results